17.3 C
New York
Wednesday, May 6, 2026
Home Blog Page 228

Children offered chickenpox vaccine on NHS

0


Michelle RobertsDigital health editor, BBC News and

Aoife WalshBBC News

Getty Images An image of a young child's back with red spots. Getty Images

Chickenpox can start with flu-like symptoms, such as a high temperature and headache.

All young children in England and Wales will be offered a free chickenpox vaccine by the NHS from January next year.

It will be given as two doses, at 12 and 18 months of age, combined with the existing MMR jab which protects against measles, mumps and rubella.

A catch up campaign is planned for slightly older children so they don’t miss out.

Until now, parents who wanted to protect their child against the chickenpox varicella virus, which causes red itchy spots, have usually had to pay up to £200 privately.

Ministers hope offering the vaccine free will not only protect youngsters from the severe, although rare, complications of chickenpox, but also save parents taking time off work to look after a sick child.

According to the Department of Health and Social Care, chickenpox causes an estimated £24m in lost income and productivity every year in the UK.

Health minister Stephen Kinnock said: “We’re giving parents the power to protect their children.

“This vaccine puts children’s health first and gives working families the support they deserve.”

The announcement comes as new data revealed none of the main childhood vaccines in England reached the 95% uptake target in 2024/25.

Some 91.9% of five-year-olds had received one dose of the MMR vaccine, unchanged from 2023/24 and the lowest level since 2010/11, according to the UKHSA.

‘Life saver’ vaccine

Chickenpox is generally mild but can be very severe for some people. Pregnant women are particularly at risk as it can cause complications for both the mother and her baby.

Very young infants and adults are also more likely to experience serious illness compared to children.

In rare cases it can cause a swelling of the brain, called encephalitis, an inflammation of the lungs, called pneumonitis, and stroke, which can result in hospitalisation and, in very rare cases, death.

The Joint Committee on Vaccination and Immunisation (JCVI), which advises UK health departments, recommended the introduction of the vaccine on the NHS in November 2023.

Experts say vaccination will dramatically reduce the number of chickenpox cases overall, leading to far fewer of the more serious ones.

Dr Gayatri Amirthalingam, deputy director of immunisation at the UK Health Security Agency (UKHSA), said vaccination could be “a life saver” for some.

Prof Adam Finn, a paediatrician who was a member of the JCVI, said chickenpox is a “rotten illness” that is often thought of as “trivial”.

The vaccine means chickenpox “is going to be a thing of the past in the near future”, he said.

The UK has lagged behind other countries in offering the jab, Prof Finn said, including the US, where it was introduced first in the 1990s.

He said the main reason for this was because chickenpox “lurks around in your body for the rest of your life” and can later come back as varicella zoster virus (VZV) or shingles. Health experts feared that if chickenpox stopped circulating, “people wouldn’t be re-exposed to the virus, their immunity would wane away and we would see more shingles”.

“Finally, we’ve now realised that concern is much, much smaller – it’s almost non-existent,” he added.

Sarah (Mia's mum) Baby Mia had a severe rash, with chickpox spots around her mouth and on her eyelidsSarah (Mia’s mum)

Baby Mia had a bad case of chickenpox, with a skin infection that needed hospital treatment

Sarah, who is a mother of two girls, says the vaccine would have helped her young daughters Willow and Mia.

Last year they both needed hospital treatment to recover from severe chickenpox.

Her youngest, Mia, developed spots “head to toe” and had a skin infection, which made her very unwell.

“She was just completely out of it…floppy.

“It was just an awful situation to be in.

“It was absolutely terrifying.”

She said she would advise parents to consider getting the vaccine: “I would never want any child or any parent to go through what we’ve been through.”

Sarah Mia's chickenpox rash was red, painful, itchy and blisteringSarah

Mia had spots all over her body

Scotland and Northern Ireland are also expected to offer the vaccine on the NHS, but have not given a date yet.

A shingles vaccine is also available on the NHS for all adults turning 65, those aged 70 to 79 and those aged 50 and over with a severely weakened immune system.

People cannot catch shingles from someone with chickenpox. But they can catch chickenpox from someone with shingles if they have not had chickenpox before.

It is possible but very unusual to get chickenpox more than once.

GOP senators express unease over RFK Jr.’s CDC shake-up

0



Two influential GOP senators are expressing unease over Health and Human Services Secretary Robert F. Kennedy Jr.’s firing of Susan Monarez as director of the Centers for Disease Control and Prevention (CDC), which led to the resignations of four other high-ranking CDC officials.

The strongest pushback among Republicans on Capitol Hill came Thursday from Sen. Bill Cassidy (R-La.), the chair of the Senate Health, Education, Labor and Pensions Committee.

He called on the department’s Advisory Committee on Immunization Practices (ACIP) to indefinitely postpone a Sept. 18 meeting in the aftermath of the staff shake-up at CDC.

“Serious allegations have been made about the meeting agenda, membership, and lack of scientific process being followed for the now announced September ACIP meeting,” Cassidy said in a statement.

Separately, Sen. Susan Collins (R-Maine) said she was “alarmed” by Monarez’s firing and echoed Cassidy’s call for congressional oversight over the decision to terminate her less than a month after her Senate confirmation.

“Susan Monarez is a highly capable scientist who brought a wealth of experience to the agency. While I recognize that the CDC Director serves at the pleasure of the President, I am alarmed that she has been fired after only three weeks on the job,” Collins said.

“Last night I talked with former Director Monarez about her removal. I agree with Chairman Bill Cassidy, who heads the Senate committee with jurisdiction over the CDC, that this matter warrants congressional oversight,” she added.

Cassidy warned the panel’s recommendations would “directly impact children’s health” and emphasized that “the meeting should not occur until significant oversight has been conducted.”

“If the meeting proceeds, any recommendations should be rejected as lacking legitimacy given the seriousness of the allegations and the current turmoil in the CDC leadership,” he said.

It’s unclear how far Cassidy, Collins or other GOP senators will go in challenging the moves, however.

The overwhelming majority of GOP senators have repeatedly sought to downplay major differences of opinion with President Trump and the most controversial members of his Cabinet this year, knowing that any criticisms of the president or his administration are certain to be met with a rebuke on Truth Social, Trump’s favorite instrument for keeping GOP lawmakers in line.

And both Cassidy and Collins are up for reelection in 2026.

GOP sources on Thursday predicted that Cassidy will be cautious in his approach to the controversy as he faces a conservative primary challenger, Louisiana Treasurer John Fleming, ahead of his 2026 reelection race.

Cassidy wants Trump’s endorsement and needs to tread carefully after he was one of seven Republican senators to vote to convict Trump on the impeachment charge of inciting insurrection during Trump’s 2021 Senate trial.

Collins, who also voted to convict Trump in that impeachment trial, is running for reelection in a state that voted for former Vice President Kamala Harris for president in 2024. That puts her in a different position from Cassidy.

The senators issued their statements after four senior CDC officials resigned from the agency following Monarez’s firing.

The four officials who resigned were Dr. Debra Houry, the CDC’s chief medical officer; Demetre Daskalakis, the agency’s top respiratory illness and immunization officer; Daniel Jernigan, a senior official who helped oversee responses to infectious diseases; and Jennifer Layden, who handled public health data.

Republican strategists warned the shake-up could underscore concerns that Kennedy is attempting to bend policy to fit a political narrative regardless of scientific reality.

One Republican strategist and former Senate GOP aide, who requested anonymity to comment candidly on the matter, said the shake-up at the agency in charge of protecting the nation’s health is proving to be an “epic” blunder.

“It’s a huge problem for CDC, for the country and for Kennedy’s credibility,” the strategist said. “He talked as if he just wanted transparency and to engage in a conversation and he’s clearly trying to cook the [books] on this point,” referring to Kennedy’s attempts to rewrite the nation’s vaccine policies.

“It seems like he’s planning on using very selectively curated, relatively opaque studies that don’t [meet] any type of normal standard of science to promulgate his view of what causes autism,” the source added.

Tom Frieden, who served as CDC director from 2009 to 2017 and is now president and CEO of Resolve to Save Lives, a global health organization, called Kennedy’s efforts to overhaul the agency an “assault” on science and sound health policy.

“It’s unprecedented. We’ve never seen the firing of a CDC director and the firing appears to have been triggered by the CDC director saying that they would not just put a rubber stamp on anything that [ACIP] said,” Frieden told The Hill in an interview.

“What we’re seeing here really is the use of ideology to make life-and-death decisions for our children. That’s unprecedented and it’s really dangerous,” he said. “I never thought I would see the day when we couldn’t rely on the CDC website for fact-based information and transparency about how it got put there, what it’s recommending and why.”

At the same time, the GOP strategist who spoke to The Hill downplayed how far any GOP resistance will go, though they predicted that Republicans could hold hearings that give Democrats a chance to get tough with Kennedy.

The strategist said Republicans can “thread the needle” by showing serious concern over Kennedy’s controversial moves without picking a fight with Trump over a core piece of his health care agenda.

One way to do that is to “have public hearings where Kennedy has to come and explain himself and put his science in public and let the world see and pick it apart,” the GOP source said.

Kennedy told Fox News’s “Fox & Friends” on Thursday that the CDC’s leadership “needs to execute Trump’s agenda” and said the agency “is in trouble” and “needs to be fixed.”

“CDC has problems. We saw the misinformation coming out of COVID, they got the testing wrong, they got the social distancing, the masks, the school closures that have done so much harm to the American people today,” he said.

White House press secretary Karoline Leavitt later on Thursday defended Trump’s decision to fire Monarez and said the president would nominate a new person to head the agency “very soon.”

Leavitt said that Trump “was overwhelmingly reelected on Nov. 5” and “this woman,” referring to Monarez, “has never received a vote in her life.”

“The president has the authority to fire those who are not aligned with his mission,” she said.

The administration on Thursday evening said Deputy Health and Human Services Secretary Jim O’Neill had been picked to serve as acting CDC director.

Daskalakis, who headed the center that issues vaccine recommendations, accused the political leadership at the Department of Health and Human Services of treating the “CDC as a tool to generate policies and materials that do not reflect scientific reality.”

The former senior health official criticized Kennedy’s decision to fire all 17 members of ACIP and replace them with people more aligned with his agenda.

In his resignation letter, which he posted on social media, Daskalakis said the reconstituted panel put “people of dubious intent and more dubious scientific rigor in charge of recommending vaccine policy to a director hamstrung and sidelined by an authoritarian leader.”

“Their desire to please a political base will result in death and disability of vulnerable children and adults,” he warned.

The Gap Between Nvidia and the Next Largest Company Is Nearly $700 Billion

0



The Gap Between Nvidia and the Next Largest Company Is Nearly $700 Billion

Famous croc wrangler found guilty in evidence tampering trial

0


Famed Australian crocodile wrangler Matt Wright has been found guilty of lying to police and pressuring a hospitalised witness after a fatal helicopter crash.

The former Netflix star was charged with three counts of perverting the course of justice over the crocodile egg harvesting disaster in 2022. A jury on Friday returned guilty verdicts for two but could not agree on the third.

Wright’s friend and Outback Wrangler co-star Chris “Willow” Wilson, who was suspended from the aircraft in a sling, died when it hit the ground. Pilot Sebastian Robinson was also seriously injured.

Prosecutors argued Wright had tried to tamper with evidence out of fear of being blamed for the crash.

Wright had pleaded not guilty to the charges, and his lawyers have already flagged they intend to appeal the verdict – which was delivered by the jury on his 46th birthday.

Walking out of the courthouse on Friday, Wright told reporters that he was “pretty disappointed in the verdict” but would “keep moving forward with this”.

“It’s been devastating for everyone involved,” he added.

While Wright was not on board during the crash, he was among the first on the scene in Arnhem Land, about 500km (310 miles) east of Darwin.

The Air Transport Safety Bureau found that the helicopter’s engine had stopped mid-flight because it had run out of fuel. The helicopter was “likely not refuelled at a fuel depot” during the journey to harvest crocodile eggs, and “the pilot did not identify the reducing fuel state”, investigators said.

Wright was convicted on Friday of lying to investigators about how much fuel was in the machine, as well as asking Mr Robinson, the injured pilot, to falsify flight records.

Prosecutors alleged that Wright had been disconnecting his helicopters’ flying-hour meters so that their long flight times – which exceeded official standards – could go undetected, and he was worried that he would be found out.

The third count, which the Supreme Court jury in Darwin failed to agree on, involves an allegation that Wright told an associate to “just torch” the helicopter’s records.

Wright was released on bail on Friday. While prosecutors sought custody for him, citing the seriousness of his offences, the judge granted Wright bail on the grounds that it was “extremely unlikely there will not be an appeal” of the verdict.

Wright is best known globally as the star of National Geographic’s Outback Wrangler and Netflix’s Wild Croc Territory reality shows. He also owns several local tourism businesses and has been a tourism ambassador for Australia.

GOP senators express unease over RFK Jr.’s CDC shake-up

0



Two influential GOP senators are expressing unease over Health and Human Services Secretary Robert F. Kennedy Jr.’s firing of Susan Monarez as director of the Centers for Disease Control and Prevention (CDC), which led to the resignations of four other high-ranking CDC officials.

The strongest pushback among Republicans on Capitol Hill came Thursday from Sen. Bill Cassidy (R-La.), the chair of the Senate Health, Education, Labor and Pensions Committee.

He called on the department’s Advisory Committee on Immunization Practices (ACIP) to indefinitely postpone a Sept. 18 meeting in the aftermath of the staff shake-up at CDC.

“Serious allegations have been made about the meeting agenda, membership, and lack of scientific process being followed for the now announced September ACIP meeting,” Cassidy said in a statement.

Separately, Sen. Susan Collins (R-Maine) said she was “alarmed” by Monarez’s firing and echoed Cassidy’s call for congressional oversight over the decision to terminate her less than a month after her Senate confirmation.

“Susan Monarez is a highly capable scientist who brought a wealth of experience to the agency. While I recognize that the CDC Director serves at the pleasure of the President, I am alarmed that she has been fired after only three weeks on the job,” Collins said.

“Last night I talked with former Director Monarez about her removal. I agree with Chairman Bill Cassidy, who heads the Senate committee with jurisdiction over the CDC, that this matter warrants congressional oversight,” she added.

Cassidy warned the panel’s recommendations would “directly impact children’s health” and emphasized that “the meeting should not occur until significant oversight has been conducted.”

“If the meeting proceeds, any recommendations should be rejected as lacking legitimacy given the seriousness of the allegations and the current turmoil in the CDC leadership,” he said.

It’s unclear how far Cassidy, Collins or other GOP senators will go in challenging the moves, however.

The overwhelming majority of GOP senators have repeatedly sought to downplay major differences of opinion with President Trump and the most controversial members of his Cabinet this year, knowing that any criticisms of the president or his administration are certain to be met with a rebuke on Truth Social, Trump’s favorite instrument for keeping GOP lawmakers in line.

And both Cassidy and Collins are up for reelection in 2026.

GOP sources on Thursday predicted that Cassidy will be cautious in his approach to the controversy as he faces a conservative primary challenger, Louisiana Treasurer John Fleming, ahead of his 2026 reelection race.

Cassidy wants Trump’s endorsement and needs to tread carefully after he was one of seven Republican senators to vote to convict Trump on the impeachment charge of inciting insurrection during Trump’s 2021 Senate trial.

Collins, who also voted to convict Trump in that impeachment trial, is running for reelection in a state that voted for former Vice President Kamala Harris for president in 2024. That puts her in a different position from Cassidy.

The senators issued their statements after four senior CDC officials resigned from the agency following Monarez’s firing.

The four officials who resigned were Dr. Debra Houry, the CDC’s chief medical officer; Demetre Daskalakis, the agency’s top respiratory illness and immunization officer; Daniel Jernigan, a senior official who helped oversee responses to infectious diseases; and Jennifer Layden, who handled public health data.

Republican strategists warned the shake-up could underscore concerns that Kennedy is attempting to bend policy to fit a political narrative regardless of scientific reality.

One Republican strategist and former Senate GOP aide, who requested anonymity to comment candidly on the matter, said the shake-up at the agency in charge of protecting the nation’s health is proving to be an “epic” blunder.

“It’s a huge problem for CDC, for the country and for Kennedy’s credibility,” the strategist said. “He talked as if he just wanted transparency and to engage in a conversation and he’s clearly trying to cook the [books] on this point,” referring to Kennedy’s attempts to rewrite the nation’s vaccine policies.

“It seems like he’s planning on using very selectively curated, relatively opaque studies that don’t [meet] any type of normal standard of science to promulgate his view of what causes autism,” the source added.

Tom Frieden, who served as CDC director from 2009 to 2017 and is now president and CEO of Resolve to Save Lives, a global health organization, called Kennedy’s efforts to overhaul the agency an “assault” on science and sound health policy.

“It’s unprecedented. We’ve never seen the firing of a CDC director and the firing appears to have been triggered by the CDC director saying that they would not just put a rubber stamp on anything that [ACIP] said,” Frieden told The Hill in an interview.

“What we’re seeing here really is the use of ideology to make life-and-death decisions for our children. That’s unprecedented and it’s really dangerous,” he said. “I never thought I would see the day when we couldn’t rely on the CDC website for fact-based information and transparency about how it got put there, what it’s recommending and why.”

At the same time, the GOP strategist who spoke to The Hill downplayed how far any GOP resistance will go, though they predicted that Republicans could hold hearings that give Democrats a chance to get tough with Kennedy.

The strategist said Republicans can “thread the needle” by showing serious concern over Kennedy’s controversial moves without picking a fight with Trump over a core piece of his health care agenda.

One way to do that is to “have public hearings where Kennedy has to come and explain himself and put his science in public and let the world see and pick it apart,” the GOP source said.

Kennedy told Fox News’s “Fox & Friends” on Thursday that the CDC’s leadership “needs to execute Trump’s agenda” and said the agency “is in trouble” and “needs to be fixed.”

“CDC has problems. We saw the misinformation coming out of COVID, they got the testing wrong, they got the social distancing, the masks, the school closures that have done so much harm to the American people today,” he said.

White House press secretary Karoline Leavitt later on Thursday defended Trump’s decision to fire Monarez and said the president would nominate a new person to head the agency “very soon.”

Leavitt said that Trump “was overwhelmingly reelected on Nov. 5” and “this woman,” referring to Monarez, “has never received a vote in her life.”

“The president has the authority to fire those who are not aligned with his mission,” she said.

The administration on Thursday evening said Deputy Health and Human Services Secretary Jim O’Neill had been picked to serve as acting CDC director.

Daskalakis, who headed the center that issues vaccine recommendations, accused the political leadership at the Department of Health and Human Services of treating the “CDC as a tool to generate policies and materials that do not reflect scientific reality.”

The former senior health official criticized Kennedy’s decision to fire all 17 members of ACIP and replace them with people more aligned with his agenda.

In his resignation letter, which he posted on social media, Daskalakis said the reconstituted panel put “people of dubious intent and more dubious scientific rigor in charge of recommending vaccine policy to a director hamstrung and sidelined by an authoritarian leader.”

“Their desire to please a political base will result in death and disability of vulnerable children and adults,” he warned.

Nat-Gas Prices Surge on Expectations of Lower-Than-Normal Inventory Build

0


September Nymex natural gas (NGU25) on Wednesday closed up +0.150 (+5.52%).

Sep nat-gas prices on Wednesday rallied sharply to a 1-week high on anticipation that Thursday’s weekly storage report will show a lower-than-normal build in nat-gas inventories.  The consensus is that EIA nat-gas inventories rose +27 bcf for the week ended August 22, below the five-year average for this time of year of +38 bcf.  Thin trading conditions exacerbated gains in nat-gas prices as Wednesday was the last trading day for the September nat-gas futures contract.

Natural gas prices have been under pressure over the past 2.5 months, dropping to a 9.5-month low in nearest-futures prices on Monday, as forecasts for cooler late-summer weather emerged.  Forecaster Vaisala said it expects lower-than-normal temperatures to blanket the US from North Carolina to Northern California from September 4-8, which will reduce demand for natural gas to run air conditioning.

Ramped-up US nat-gas production is another bearish factor for prices.  On August 12, the EIA raised its forecast for 2025 US nat-gas production by +0.5% to 106.44 bcf/day from July’s estimate of 105.9 bcf/day.  The EIA raised its forecast for 2026 US nat-gas production by +0.7% to 106.09 from July’s 105.4 bcf/day forecast.  US nat-gas production is currently near a record high, with active US nat-gas rigs recently posting a 2-year high.

US (lower-48) dry gas production on Wednesday was 107.7 bcf/day (+4.5% y/y), according to BNEF.  Lower-48 state gas demand on Wednesday was 72.4 bcf/day (-15.2% y/y), according to BNEF.  Estimated LNG net flows to US LNG export terminals on Wednesday were 15.5 bcf/day (+11.7% w/w), according to BNEF.

As a supportive factor for gas prices, the Edison Electric Institute reported Wednesday that US (lower-48) electricity output in the week ended August 23 rose +7.7% y/y to 95,130 GWh (gigawatt hours), and US electricity output in the 52-week period ending August 23 rose +3.1% y/y to 4,270,960 GWh.

Last Thursday’s weekly EIA report was bullish for nat-gas prices since nat-gas inventories for the week ended August 15 rose +13 bcf, below the consensus of +18 bcf and well below the 5-year weekly average of +35 bcf.  As of August 15, nat-gas inventories were down -3.0% y/y, but were +5.8% above their 5-year seasonal average, signaling adequate nat-gas supplies.  As of August 24, gas storage in Europe was 76% full, compared to the 5-year seasonal average of 84% full for this time of year.

White House names RFK Jr deputy Jim O’Neill as replacement CDC director

0


The White House has named a replacement for the director of the US Centres for Disease Control and Prevention (CDC), a day after its previous leader was forced out of the job.

Jim O’Neill currently serves as the deputy to Health Secretary Robert F Kennedy Jr, and will replace Susan Monarez after she was in the role for just a month.

Lawyers representing Dr Monarez said her sacking was illegal, and alleged she was targeted by Kennedy because she refused “to rubber-stamp unscientific, reckless directives”.

The reason for her removal was that she was “not aligned with the president’s agenda”, the White House said in a statement.

O’Neill is a former Silicon Valley tech investor and takes over the CDC at a time when some of its leading officials are deeply divided over vaccine policies.

At least three senior CDC leaders have since resigned from the agency, some citing frustration over vaccine policy and the leadership of Kennedy, also known as RFK Jr.

Among them was Chief Medical Officer Debra Houry, who warned about the “rise of misinformation” about vaccines in a letter seen by the BBC’s US partner CBS News. She also argued against planned cuts to the agency’s budget.

A long-time federal government scientist, Dr Monarez was nominated by President Donald Trump to lead the CDC and was confirmed in a Senate vote along party lines in July.

Her nomination followed Trump withdrawing his first pick, former Republican Congressman Dave Weldon, who had come under fire for his views on vaccines and autism.

On Wednesday, Dr Monarez’s lawyers issued a statement saying that she had chosen “protecting the public over serving a political agenda”.

The White House statement announcing the termination of her post said: “As her attorney’s statement makes abundantly clear, Susan Monarez is not aligned with the president’s agenda.”

On Thursday, Kennedy told Fox & Friends on Fox News that the CDC leadership “needs to execute Trump’s agenda”.

The CDC, he added, “is in trouble, needs to be fixed”.

The New York Times reports that she was at odds with Kennedy, a vaccine sceptic, over vaccine policy.

The White House has said they will name her replacement shortly.

“If people are not aligned with the President’s vision and the Secretary’s vision to make this country healthy again, then we will gladly show them the door,” White House Press Secretary Karoline Leavitt said on Thursday about the multiple exits.

The exodus at the top of one of the world’s most foremost public health bodies comes as health experts voice concern over the agency’s approach to immunisations since Kennedy took over.

Senator Bernie Sanders, who is the ranking member of the Senate Health, Education, Labor and Pensions (HELP) said the sacking was “reckless” and “dangerous” and called for an investigation into the firing of Dr Monarez.

Daniel Jernigan, who led the National Center for Emerging and Zoonotic Infectious Diseases, was one of those to quit citing “the current context in the department”.

Head of the National Center for Immunization and Respiratory Diseases, Demetre Daskalakis, also said he was no longer able to serve “because of the ongoing weaponising of public health”.

There are also reports, including by NBC News, that Dr Jennifer Layden, director of the Office of Public Health Data, Surveillance and Technology, has also resigned.

Earlier on Wednesday, the Food and Drug Administration (FDA) approved new Covid vaccines while limiting who could receive them.

The vaccines will be available for all seniors, but younger adults and children without underlying health conditions will be excluded.

“The emergency use authorizations for Covid vaccines, once used to justify broad mandates on the general public during the Biden administration, are now rescinded,” Kennedy wrote on X.

Dr Monarez was the first CDC director in 50 years to not hold a medical degree. Her background is in infectious disease research.

In her month as the CDC leader, she helped comfort agency employees after the CDC’s headquarters in Atlanta was attacked by a gunman who believed he had been harmed by Covid vaccines.

The attack, in which hundreds of bullets struck the building, killed one police officer.

Earlier this month, current and former employees of the agency wrote an open letter accusing Kennedy of fuelling violence towards healthcare workers with his anti-vaccine rhetoric.

Dr Monarez’s departure comes about a week after a union representing CDC employees announced that about 600 CDC employees had been fired.

The wide-ranging layoffs included employees working on the government’s response to infectious diseases, including bird flu, as well as those researching environmental hazards and handling public record requests.

Kari Lake can't fire Voice of America director, judge says

0



A federal judge on Thursday barred the Trump administration from removing Voice of America’s (VOA) director Michael Abramowitz from his post.

U.S. District Judge Royce Lamberth ruled that Kari Lake, President Trump’s top advisor to the U.S Agency for Global Media, cannot fire Abramowitz, who was told he would be “subject to termination” starting Aug. 31, according to court documents.

The ruling states that Abramowitz can only be removed from his position as director by a majority vote of the International Broadcasting Advisory Board.

“The applicable statutory requirements could not be clearer: the director of Voice of America ‘may only be removed if such action has been approved by a majority vote’” Lamberth wrote.

“The merits are decided, and there is no longer a question of whether the termination was unlawful,” Lamberth added.

Abramowitz, who was appointed director of VOA in 2019, was previously placed on administrative leave as Lake slashed the number of employees at the government-funded global news agency. 

“This dispute arises from yet another twist in the saga of the U.S. Agency for Global Media’s efforts to dial back the operations of Voice of America contrary to statuary requirements,” Lamberth wrote in the ruling.

VOA has been a target of the Trump administration, which seeks to transform it into an “America First” outlet — an effort that Republicans have largely applauded.

HPE Price Target Raised to $28 as Corporate AI Spending Accelerates

0


Hewlett-Packard Enterprise Company (NYSE:HPE) is one of the AI Stocks Analysts Are Tracking Closely. On August 21, Morgan Stanley analyst Erik Woodring upgraded the stock from Equalweight to Overweight with a price target of $28.00 (from $22.00).

The firm’s rating affirmation reflects increased corporate spending on HPE’s artificial intelligence (AI) and other products.

The analysts noted that their “checks signaled healthy enterprise spending across the board in the quarter, led by anything AI compute or networking related, followed by client devices (strong PC refresh), and then servers/storage, with networking growth inflecting positively for the first time in several quarters.”

HPE Price Target Raised to $28 as Corporate AI Spending Accelerates
HPE Price Target Raised to $28 as Corporate AI Spending Accelerates

The firm looks forward to HPE’s Analyst Day on October 15, as the most important upcoming catalyst for the company.

“We are upgrading HPE to Overweight (from Equal-Weight) with a new $28 price target, or 11x our new FY26 EPS of $2.51. Our thesis is straight-forward – with the closure of JNPR, we see 18% upside to FY26 Consensus EPS, with EPS growing to $2.70-3.00 in FY27, and believe that as the market comes to better understand nearly half of HPE’s business is networking, inclusive of more AI exposure (JNPR in xAI cluster), HPE’s multiple will re-rate above the current 8x multiple. Our 11x target P/E multiple doesn’t even assume HPE garners a peer average multiple, and yet we still see 33% upside to shares from here. The biggest risks to our call are (1) execution — deals always look better on paper than in real-life and the risk here is that this deal is no different / the synergies mgmt outlined don’t materialize as expected, (2) JNPR/Aruba underperforms outside of the xAI exposure as competition is intense in networking and campus upgrade exposure is relatively limited (with risk of JNPR CEO leaving eventually), and (3) FCF and/or capital returns continue to disappoint vs. expectations.”

Hewlett Packard Enterprise Company (NYSE:HPE), an American multinational technology company, provides high-performance computing systems, AI software, and data storage solutions for running complex AI workloads.

While we acknowledge the potential of HPE as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 10 Must-Watch AI Stocks for Investors and 10 AI Stocks Analysts Are Tracking Closely

Disclosure: None.

UK firms warn over US small parcel tax

0


Charlotte Edwards & Emer MoreauBusiness reporters, BBC News

Helen Hickman Helen, a small business owner, stands by a tree with her long brown hair blowing in the wind.Helen Hickman

Helen Hickman says new taxes on small parcels are causing “an absolute chaotic mess”.

UK firms are warning that new taxes on sending low-value parcels to the US are bringing uncertainty and potential price hikes for their businesses.

US President Donald Trump cutting the “de minimis” exemption means parcels valued under $800 (£592) will be subject to tax from Friday.

The Federation of Small Businesses has warned this will push up costs and create new barriers for small firms in the UK trying to compete with bigger brands.

“I knew it was going to be an absolute chaotic mess,” said Helen Hickman, who has stopped shipping wool to the US due to uncertainty about the costs.

Her hand-dyed wool company, Nellie and Eve, in Carmarthenshire, west Wales, used to make about 30% of its sales to the US – but she has put them on hold.

“I didn’t have enough information to be able to comfortably say that I could ship as normal,” she says. “There is no way of giving the customer an upfront cost.”

“I didn’t want products to be excessively charged or returned to me or lost,” she says.

Helen Hickman Helen stands surrounded by wool from her businessHelen Hickman

The changes mean packages valued at under $800 will face the same tariff rate as other goods from their country of origin – for the UK that’s 10%.

Previously, the de minimis exemption meant goods valued at $800 or less could enter the US without paying any border taxes.

US consumers used the exemption to buy cheap clothes and household items from online commerce sites like Shein and Temu, as well as from countries other than China.

But from Friday, “a typical $100 order could now incur an additional $30 to $50 in costs, depending on the final sales tax rate adopted by US authorities,” says Martin Hamilton, partner and head of retail at accountancy firm Menzies.

“On top of that, brands will face extra fees from shipping providers for handling duties and taxes,” he says.

Earlier this month, postal services around the world paused some deliveries to the US over confusion around the new rules.

The Royal Mail says it has been working with the US authorities and international partners so its services will meet the new US de minimis requirements when they come into effect on Friday.

Jay Begum sells handmade wooden decorations and gifts through her small London-based business Knots of Pine.

She had already noticed a slowdown in orders from the US since President Trump announced tariffs earlier in the year, because it made American customers more jittery in general.

But now the de minimis tax change is having an even bigger impact, and she has decided to no longer ship to the US at all.

As the country makes up about 20% of her sales, it’s a significant hit. “Now, I only have the UK market,” she says.

Jay will have to put more money into marketing to boost her domestic sales if she is unable to start selling to the US again.

“It would be a lot of work, to claw back the sales that I’m losing.”

Tina McKenzie, policy chair of the Federation of Small Businesses, says: “Small firms in the UK have already been hit by US tariffs, with just over two in ten saying they have stopped, or may stop, exporting there altogether.”

She added: “The US Administration’s decision to scrap the de minimis threshold, combined with postal carriers temporarily suspending deliveries in response, will push up costs and create new barriers.”

Statistics published by HMRC show that in 2023 around 28,000 small businesses – companies with less than 49 employees – exported goods to the US.

‘I might have to get another job’

Sophie Arnold runs a small jewellery business, the Little Vintage Emporium in Edinburgh, and stopped shipping to the US when she heard the $800 exemption was ending.

She says it will have a negative impact on her business.

“America is our main market,” she adds.

Ms Arnold thinks “big hitters” in the antique world may have the finances to pay extra duties, but says smaller businesses like hers will suffer.

“I might have to look at returning into an office or doing other jobs and not running my business full time,” she says.

The FSB says it wants the UK government to provide more support.

Ms McKenzie says raising the Trading Allowance – a tax-free allowance for casual income – from £1,000 to £3,000 would “make it easier for people to sell more, helping them cope with the extra costs that tariffs will bring in”.

“The UK and US should be working together to make it easier for small businesses to reach customers across the Atlantic. That means clear, practical rules, time to adapt, and systems that keep trade moving,” Ms Mckenzie added.

The BBC has asked the UK Treasury for comment.

In April, the UK government announced it was reviewing its own de minimis rules.

Low-value imports, which are worth £135 or less, are currently exempt from customs duties.